Cancer cells containing extrachromosomal DNAs (ecDNAs) have a weakness that can be targeted with a drug that targets the CHK1 protein, a new study shows.

Most studies of genome organization have focused on intrachromosomal (<i>cis</i>) contacts because they harbor key features such as DNA loops and topologically associating domains. Interchromosomal (<...